BiomX to Report Third Quarter 2025 Financial Results and Program Updates on November 12, 2025
BiomX (NYSE American: PHGE) will report third quarter 2025 financial results and program updates before U.S. market open on Wednesday, November 12, 2025. The company will host a conference call and live audio webcast at 8:30 AM ET to discuss results and program progress.
Registration is recommended at least 5 minutes before the call; the webcast will be live and archived on the company website.
BiomX (NYSE American: PHGE) will report terzo trimestre 2025 risultati finanziari e aggiornamenti del programma prima dell'apertura dei mercati statunitensi di mercoledì 12 novembre 2025. L'azienda ospiterà una conference call e una webcast audio in diretta alle 8:30 AM ET per discutere i risultati e i progressi del programma.
Si consiglia di registrarsi almeno 5 minuti prima della chiamata; la webcast sarà in diretta e archiviata sul sito web dell'azienda.
BiomX (NYSE American: PHGE) informará tercero trimestre de 2025 resultados financieros y actualizaciones del programa antes de la apertura del mercado de EE. UU. el miércoles 12 de noviembre de 2025. La empresa organizará una llamada de conferencia y una transmisión en vivo por web a las 8:30 AM ET para debatir los resultados y el progreso del programa.
Se recomienda registrarse al menos 5 minutos antes de la llamada; la transmisión estará en vivo y se almacenará en el sitio web de la empresa.
BiomX(NYSE American: PHGE)은 미국 시장 개장 전에 2025년 3분기 재무 결과 및 프로그램 업데이트를 발표하며 2025년 11월 12일 수요일에 진행됩니다. 회사는 결과 및 프로그램 진행 상황을 논의하기 위해 동부 표준시 기준 8:30 AM에 컨퍼런스 콜 및 실시간 오디오 웹캐스트를 개최합니다.
콜 시작 최소 5분 전에 등록하는 것이 권장되며, 웹캐스트는 라이브로 제공되며 회사 웹사이트에 보관됩니다.
BiomX (NYSE American: PHGE) publiera les résultats du troisième trimestre 2025 et les mises à jour du programme avant l'ouverture du marché américain le mercredi 12 novembre 2025. L'entreprise organisera une conférence téléphonique et une webdiffusion audio en direct à 8 h 30, heure de l’Est pour discuter des résultats et des progrès du programme.
L'inscription est recommandée au moins 5 minutes avant l'appel ; la webdiffusion sera en direct et archivée sur le site Web de l'entreprise.
BiomX (NYSE American: PHGE) wird die Finanzergebnisse des dritten Quartals 2025 und Programmupdates vor der US-Börsenöffnung am Mittwoch, dem 12. November 2025 berichten. Das Unternehmen wird eine Konferenzschaltung und einen Live-Audio-Webcast um 8:30 Uhr ET abhalten, um Ergebnisse und Programmfortschritte zu besprechen.
Es wird empfohlen, sich mindestens 5 Minuten vor dem Anruf zu registrieren; der Webcast wird live sein und auf der Unternehmenswebseite archiviert.
ביומאקס (BiomX) (بورصة نيويورك الأمريكية: PHGE) سيُعلن عن نتائج الربع الثالث من 2025 وتحديثات البرنامج قبل افتتاح السوق الأمريكي يوم الأربعاء 12 نوفمبر 2025. ستستضيف الشركة مكالمة مؤتمريه وبثًا صوتيًا حيًا عبر الويب في 8:30 صباحًا بتوقيت شرق الولايات المتحدة لمناقشة النتائج وتقدم البرنامج.
يوصى بالتسجيل على الأقل قبل 5 دقائق من الاتصال؛ سيكون البث المباشر متاحًا ومؤرشفًا على موقع الشركة الإلكتروني.
- None.
- None.
NESS ZIONA, Israel, Nov. 05, 2025 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today announced that it will report its third quarter 2025 financial results and program updates before the open of the U.S. financial markets on Wednesday, November 12, 2025. The Company will host a conference call and a live audio webcast at 8:30 a.m. ET, to discuss the third quarter of 2025 financial results and provide program updates.
To ensure you are connected prior to the beginning of the call, BiomX suggests registering a minimum of 5 minutes before the start of the call. For those not planning to ask a question of management, the Company recommends listening via the webcast.
Conference Call Dial-In & Webcast Information:
| Date: | Wenesday, November 12, 2025 |
| Time: | 8:30 AM Eastern Time |
| Conference Call | https://register-conf.media-server.com/register/BIf7434533b852452a822a8e5f48b669e2 |
| Webcast: | https://edge.media-server.com/mmc/p/s6tntmgo |
The live and archived webcast will also be available in the Investors section of the Company’s website at www.biomx.com.
About BiomX
BiomX is a clinical-stage company leading the development of natural and engineered phage cocktails and personalized phage treatments designed to target and destroy harmful bacteria for the treatment of chronic diseases with substantial unmet needs. BiomX discovers and validates proprietary bacterial targets and applies its BOLT (“BacteriOphage Lead to Treatment”) platform to customize phage compositions against these targets. For more information, please visit www.biomx.com, the content of which does not form a part of this press release.
Contacts:
BiomX, Inc.
Ben Cohen
Head Corporate Communications
benc@biomx.com
FAQ
When will BiomX (PHGE) report third quarter 2025 results?
What time is the BiomX (PHGE) Q3 2025 conference call and webcast?
How can investors join the BiomX (PHGE) November 12, 2025 webcast?
Is registration required for the BiomX (PHGE) November 12, 2025 call?
Where will the archived BiomX (PHGE) Q3 2025 webcast be available?
